A
Ambani, Lalit
- Levodopa and cholinergic hypersensitivity in Parkinson's diseaseMelvin H. Van Woert, Lalit Ambani, Malcolm B. Bowers
Antunes, Joao-Lobo
- Autopsy findings in parkinsonism following treatment with levodopaMelvin D. Yahr, Abner Wolf, Joao-Lobo Antunes, Koho Miyoshi, Philip Duffy
B
Barbeau, A.
- Panel discussionLong‐term safety and efficacy of levodopaC. H. Markham, A. Barbeau, H. M. Langrall, F. McDowell, M. D. Yahr
Barbeau, André
Bowers, Malcolm B.
- Levodopa and cholinergic hypersensitivity in Parkinson's diseaseMelvin H. Van Woert, Lalit Ambani, Malcolm B. Bowers
Brodie, B. B.
- Mechanism of actionPanel discussionS. Spector, B. B. Brodie, G. C. Cotzias, Van Woert, R. J. Wurtman
Burns, John J.
C
Cotzias, G. C.
- Mechanism of actionPanel discussionS. Spector, B. B. Brodie, G. C. Cotzias, Van Woert, R. J. Wurtman
Cotzias, George C.
- Some newer metabolic concepts in the treatment of parkinsonismGeorge C. Cotzias, Paul S. Papavasiliou, Simone E. Düby, Andreas J. Steck, James Z. Ginos
D
Düby, Simone E.
- Some newer metabolic concepts in the treatment of parkinsonismGeorge C. Cotzias, Paul S. Papavasiliou, Simone E. Düby, Andreas J. Steck, James Z. Ginos
Duffy, Philip
- Autopsy findings in parkinsonism following treatment with levodopaMelvin D. Yahr, Abner Wolf, Joao-Lobo Antunes, Koho Miyoshi, Philip Duffy
G
Ginos, James Z.
- Some newer metabolic concepts in the treatment of parkinsonismGeorge C. Cotzias, Paul S. Papavasiliou, Simone E. Düby, Andreas J. Steck, James Z. Ginos
J
Joseph, Clifford
- Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndromeResults of a collaborative studyHarrison M. Langrall, Clifford Joseph
L
Langrall, H. M.
- Panel discussionLong‐term safety and efficacy of levodopaC. H. Markham, A. Barbeau, H. M. Langrall, F. McDowell, M. D. Yahr
Langrall, Harrison M.
- Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndromeResults of a collaborative studyHarrison M. Langrall, Clifford Joseph
M
Markham, C. H.
- Panel discussionLong‐term safety and efficacy of levodopaC. H. Markham, A. Barbeau, H. M. Langrall, F. McDowell, M. D. Yahr
Markham, Charles H.
McDowell, F.
- Panel discussionLong‐term safety and efficacy of levodopaC. H. Markham, A. Barbeau, H. M. Langrall, F. McDowell, M. D. Yahr
Miyoshi, Koho
- Autopsy findings in parkinsonism following treatment with levodopaMelvin D. Yahr, Abner Wolf, Joao-Lobo Antunes, Koho Miyoshi, Philip Duffy
N
Ngai, S. H.
P
Papavasiliou, Paul S.
- Some newer metabolic concepts in the treatment of parkinsonismGeorge C. Cotzias, Paul S. Papavasiliou, Simone E. Düby, Andreas J. Steck, James Z. Ginos
R
Riklan, Manuel
Romero, J. A.
S
Spector, S.
- Mechanism of actionPanel discussionS. Spector, B. B. Brodie, G. C. Cotzias, Van Woert, R. J. Wurtman
Steck, Andreas J.
- Some newer metabolic concepts in the treatment of parkinsonismGeorge C. Cotzias, Paul S. Papavasiliou, Simone E. Düby, Andreas J. Steck, James Z. Ginos
V
Van Woert, Melvin H.
- Levodopa and cholinergic hypersensitivity in Parkinson's diseaseMelvin H. Van Woert, Lalit Ambani, Malcolm B. Bowers
W
Wiklund, Richard A.
Woert, Van
- Mechanism of actionPanel discussionS. Spector, B. B. Brodie, G. C. Cotzias, Van Woert, R. J. Wurtman
Wolf, Abner
- Autopsy findings in parkinsonism following treatment with levodopaMelvin D. Yahr, Abner Wolf, Joao-Lobo Antunes, Koho Miyoshi, Philip Duffy
Wurtman, R. J.
- Mechanism of actionPanel discussionS. Spector, B. B. Brodie, G. C. Cotzias, Van Woert, R. J. Wurtman
Y
Yahr, M. D.
- Panel discussionLong‐term safety and efficacy of levodopaC. H. Markham, A. Barbeau, H. M. Langrall, F. McDowell, M. D. Yahr
Yahr, Melvin D.
- Autopsy findings in parkinsonism following treatment with levodopaMelvin D. Yahr, Abner Wolf, Joao-Lobo Antunes, Koho Miyoshi, Philip Duffy
Advertisement
Popular on
Neurology

Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Advertisement